Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/1999
06/03/1999WO1999014333A3 Improved method of production of pneumococcal surface proteins
06/03/1999WO1999013907A3 Methods to improve immunogenicity of antigens and specificity of antibodies
06/03/1999WO1999012965A3 April- a novel protein with growth effects
06/03/1999WO1999012566A9 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/03/1999WO1999011275A3 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
06/03/1999WO1998037089A8 Matrix derived anti-hiv peptides and transdominant proteins
06/03/1999CA2311809A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor
06/03/1999CA2311759A1 Recombinant mycoplasma hyopneumoniae vaccine
06/03/1999CA2310987A1 Tnf ligand family gene
06/03/1999CA2310805A1 Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
06/03/1999CA2310565A1 Human protein kinase and kinase inhibitors
06/03/1999CA2310217A1 Extracellular matrix-binding proteins from staphylococcus aureus
06/03/1999CA2309809A1 Histamine and serotonin binding molecules
06/03/1999CA2309358A1 A-33 related antigens and their pharmacological uses
06/03/1999CA2307846A1 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/02/1999EP0919617A1 Anti-human mp52 monoclonal antibody
06/02/1999EP0919568A1 Escape mutant of the surface antigen of hepatitis B virus
06/02/1999EP0919243A1 Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
06/02/1999EP0918872A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis
06/02/1999EP0918868A2 Antimicrobial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components
06/02/1999EP0918865A1 Immunologically active proteins of borrelia burgdorferi, coded nuclein acids of such and their use in test kits and vaccines
06/02/1999EP0918864A2 PROTEINS, IN PARTICULAR MEMBRANE PROTEINS, OF $i(HELICOBACTER PYLORI), THEIR PREPARATION AND USE
06/02/1999EP0918859A1 Testis-specific insulin homolog polypeptides
06/02/1999EP0918858A1 Common gamma chain blocking agents
06/02/1999EP0918856A2 Two human nsp-like proteins
06/02/1999EP0918848A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
06/02/1999EP0918797A2 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH $g(a)4$g(b)7 INTEGRIN
06/02/1999EP0918796A1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein
06/02/1999EP0918788A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer
06/02/1999EP0918545A2 Tumour therapy
06/02/1999EP0918541A1 Immunstimulating lipid formulation
06/02/1999EP0918540A1 Intradermal bovine polynucleotide vaccine
06/02/1999EP0918539A1 Vaccine for b-cell malignancies
06/02/1999EP0918532A1 A novel method of detecting and treating cancer
06/02/1999EP0918528A1 Method for treating gastrointestinal damage
06/02/1999EP0918524A1 Mixed chimerism and tolerance
06/02/1999EP0918458A1 Antimicrobial treatment for herpes simplex virus and other infectious diseases
06/02/1999EP0845036B1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/02/1999EP0804234B1 Vaccine adjuvant
06/02/1999EP0680513B1 Lysosomal targeting of immunogens
06/02/1999EP0675729B1 ACTIVATION OF p53 PROTEIN
06/02/1999CN1218513A Vectors based on recombinant defenctive viral genmoes, and their use in formulation of vaccines
06/02/1999CN1218512A Recombinant adenoviral vectors for human tumour gene therapy
06/02/1999CN1218412A Peptide-base immunotherapeutic agent for allergic diseases
06/02/1999CN1218411A Method of killing target cells in harvested cell populations
06/02/1999CN1218406A HLA-A2.1 binding peptides and their uses
06/02/1999CN1218404A HLA binding peptides and their uses
06/02/1999CA2223075A1 Drug binding protein
06/01/1999US5908839 Administering mixture of tyrosine kinase inhibitor and amino sterol
06/01/1999US5908826 Freeze-dried preparation containing monoclonal antibody
06/01/1999US5908825 Dosage composition for nasal delivery and method of use of the same
06/01/1999US5908780 Cells transformed or transfected with HCMV US2 gene
06/01/1999US5908778 Mage-10 encoding cDNA, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof
06/01/1999US5908630 Toxin secreting bacteria; pneumonia
06/01/1999US5908627 Antigen associated with Type I diabetes mellitus
06/01/1999US5908626 Genetic engineering
06/01/1999US5908624 Linker molecule covalently attached to said cell surface; and a non-immunogenic compound covalently attached to said linker molecule and blocking recognition of said antigenic determinants on said cell surface
06/01/1999CA2251260A1 Escape mutant of the surface antigen of hepatitis b virus
06/01/1999CA1340577C Recombinant systems for expressions of cholera b-subunit with the aid of foreign promoters and/or leader peptides
05/1999
05/27/1999WO1999026068A1 A method and device for preventing immunoglobulin degradation in external secretions
05/27/1999WO1999025877A1 Reagents and methods useful for detecting diseases of the breast
05/27/1999WO1999025860A1 Vector for tissue-specific replication and gene expression
05/27/1999WO1999025858A1 Alphavirus vectors for paramyxovirus vaccines
05/27/1999WO1999025838A1 Compositions and methods to prevent turkey enteritis
05/27/1999WO1999025837A2 Method for producing virus-like particles on the basis of polyoma viruses
05/27/1999WO1999025836A1 Attaching substances to micro-organisms
05/27/1999WO1999025832A1 Toso
05/27/1999WO1999025830A1 Transcriptionally regulated g protein-coupled receptor
05/27/1999WO1999025829A2 Cdk2 protein and cdk2 protein complexes
05/27/1999WO1999025828A1 A human 2-19 protein homologue, z219c
05/27/1999WO1999025823A2 Recombinant allergen with reduced enzymatic activity
05/27/1999WO1999025818A1 Method of identifying binding site domains that retain the capacity of binding to an epitope
05/27/1999WO1999025815A2 Nucleic acids involved in the responder phenotype and applications thereof
05/27/1999WO1999025737A1 Compositions and methods for treatment of autoimmune diseases, using a monoclonal antibody to the interleukin-12 beta2-chain
05/27/1999WO1999025734A2 Th2 CELL DEPLETION; COMPOSITIONS; METHODS
05/27/1999WO1999025387A1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype
05/27/1999WO1999025381A1 Linear antigen supporting units
05/27/1999WO1999025380A2 Methods and compositions for the treatment of psoriasis
05/27/1999WO1999025379A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
05/27/1999WO1999025378A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
05/27/1999WO1999025377A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
05/27/1999WO1999025376A1 Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens
05/27/1999WO1999025367A2 Treatment of hematologic disorders
05/27/1999WO1999025341A1 Use of histamine for elevating blood histamine levels
05/27/1999WO1999014330A8 DcR3 POLYPEPTIDE, A TNFR HOMOLOG
05/27/1999WO1999013908A9 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
05/27/1999WO1999013092A9 Enhancement of mucosal antibody responses by interleukin-6
05/27/1999WO1999013084A9 Group a streptococcal vaccines
05/27/1999WO1999012964A3 Kay - a novel immune system protein
05/27/1999WO1999012960A3 P13 ANTIGENS FROM $i(BORRELIA)
05/27/1999WO1999012563A3 Mucosal cytotoxic t lymphocyte responses
05/27/1999WO1999011660A3 Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions
05/27/1999WO1998055495A3 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
05/27/1999WO1998049292A3 Polypeptides associated with activator receptors and their biological applications
05/27/1999CA2320399A1 A human 2-19 protein homologue, z219c
05/27/1999CA2310713A1 Direct cytotoxic activity by anti-hcg monoclonal antibodies
05/27/1999CA2310563A1 Vector for tissue-specific replication and gene expression
05/27/1999CA2310462A1 Linear antigen supporting units
05/27/1999CA2310269A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
05/27/1999CA2310255A1 Use of histamine for elevating blood histamine levels
1 ... 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 ... 1823